Cambrian Bio

“A distributed pipeline of aging medicines under one parent.”

James Peyer’s Cambrian incubates and owns multiple longevity pipeline companies. The org is a portfolio that acts like a pharma.

Therapeutics as a studio.

Series A. Filed from the Top Tier Impact landscape.

A pharma of aging.

Also in this file